NAFLD
Clinical trials for NAFLD explained in plain language.
Never miss a new study
Get alerted when new NAFLD trials appear
Sign up with your email to follow new studies for NAFLD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug may also fight fatty liver
Disease control Not yet recruitingThis study looks at whether a GLP-1 RA drug (used for diabetes and weight loss) can improve fat levels in the liver and blood of people with MASLD (fatty liver disease). About 30 adults with MASLD, diabetes, and obesity will take the drug and have liver biopsies and blood tests t…
Matched conditions: NAFLD
Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Can a citrus compound and vitamin c tame fatty liver?
Disease control Not yet recruitingThis study tests whether adding rutin (a plant compound found in citrus) to vitamin C can reduce liver inflammation and fat buildup in people with metabolic fatty liver disease (MASLD). About 120 adults will take either rutin plus vitamin C or vitamin C alone for 12 weeks. The go…
Matched conditions: NAFLD
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Gut bugs and gym: new combo tackles fatty liver
Disease control Not yet recruitingThis study looks at whether taking probiotics (good bacteria) along with doing resistance exercise can help people with fatty liver disease. The goal is to see if this combination reduces liver fat and improves health. The study will involve 180 adults aged 18-60 who have been di…
Matched conditions: NAFLD
Phase: NA • Sponsor: Nicolaus Copernicus University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a diabetes pill help teens with fatty liver? new trial aims to find out.
Disease control Not yet recruitingThis study tests whether a type 2 diabetes medicine (SGLT2 inhibitor) can safely reduce liver fat in adolescents aged 12-20 who have obesity and non-alcoholic fatty liver disease (NAFLD). About 40 participants will receive either the drug or a placebo for a set period. The main g…
Matched conditions: NAFLD
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug aims to shrink fatty liver in diabetes patients
Disease control Not yet recruitingThis early-stage study tests whether a drug called Henggliejin can improve fatty liver in people with type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). About 149 adults will take the drug for 48 weeks. Researchers will check liver health using a simple blood test call…
Matched conditions: NAFLD
Phase: EARLY_PHASE1 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
Eat in 8 hours, beat fatty liver? new trial tests timing
Disease control Not yet recruitingThis study tests whether eating only during an 8-hour window each day (time-restricted eating) can help people with fatty liver disease (MASLD) lose weight and reduce body fat. 150 adults will follow this eating pattern for 3 months, with some also limiting fruit and vegetable in…
Matched conditions: NAFLD
Phase: NA • Sponsor: Cyprus University of Technology • Aim: Disease control
Last updated May 04, 2026 16:24 UTC